West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 493,700 | 361,600 | 221,600 | 89,800 | 492,700 |
| Depreciation Amortization | 171,400 | 124,400 | 81,400 | 40,000 | 155,400 |
| Income taxes - deferred | -13,700 | N/A | N/A | N/A | -3,500 |
| Accounts receivable | 6,900 | N/A | N/A | N/A | -58,800 |
| Accounts payable and accrued liabilities | 17,900 | N/A | N/A | N/A | 2,900 |
| Other Working Capital | 79,800 | -1,900 | -4,000 | 100 | 2,900 |
| Other Operating Activity | -1,200 | 19,600 | 7,500 | -500 | 61,800 |
| Operating Cash Flow | $754,800 | $503,700 | $306,500 | $129,400 | $653,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -285,900 | -209,800 | -146,500 | -71,300 | -377,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,700 |
| Investing Cash Flow | $-285,900 | $-209,800 | $-146,500 | $-71,300 | $-378,700 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | N/A | 164,700 |
| Debt Repayment | -1,100 | -800 | -500 | -200 | -192,300 |
| Common Stock Issued | 18,200 | 13,600 | 9,600 | 4,400 | 32,700 |
| Common Stock Repurchased | -136,800 | -136,600 | -136,500 | -136,000 | -566,600 |
| Dividend Paid | -61,200 | -45,400 | -30,300 | -15,200 | -59,100 |
| Other Financing Activity | -4,200 | -4,200 | -4,200 | 0 | -2,000 |
| Financing Cash Flow | $-185,100 | $-173,400 | $-161,900 | $-147,000 | $-622,600 |
| Exchange Rate Effect | 22,900 | 23,400 | 27,000 | 8,500 | -21,400 |
| Beginning Cash Position | 484,600 | 484,600 | 484,600 | 484,600 | 853,900 |
| End Cash Position | 791,300 | 628,500 | 509,700 | 404,200 | 484,600 |
| Net Cash Flow | $306,700 | $143,900 | $25,100 | $-80,400 | $-369,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 754,800 | 503,700 | 306,500 | 129,400 | 653,400 |
| Capital Expenditure | -285,900 | -209,800 | -146,500 | -71,300 | -377,000 |
| Free Cash Flow | 468,900 | 293,900 | 160,000 | 58,100 | 276,400 |